Research Article
Clinical Efficacy and Adverse Reactions of Bevacizumab plus Radiochemotherapy in the Treatment of Advanced Gastric Cancer
Table 5
Comparison of the incidence of adverse reactions in the two groups (n/%).
| | Adverse reactions | Research group (n = 43) | Control group (n = 43) | | I | II | III | Total incidence | I | II | III | Total incidence |
| | Nausea and vomiting | 12 | 5 | 1 | 18/41.86 | 10 | 6 | 0 | 16/37.21 | | Thrombocytopenia | 2 | 3 | 1 | 6/13.95 | 3 | 1 | 1 | 5/11.63 | | Leukopenia | 7 | 10 | 4 | 21/48.84 | 8 | 8 | 3 | 19/44.19 | | Peripheral neurotoxicity | 2 | 1 | 0 | 3/6.98 | 1 | 0 | 0 | 1/2.33 | | Abnormal liver and kidney function | 9 | 6 | 2 | 17/39.53 | 7 | 7 | 0 | 14/32.56 | | Bone marrow suppression | 7 | 5 | 1 | 13/30.23 | 8 | 3 | 0 | 11/25.58 |
|
|
